Haberler›Güncel›Novo Nordisk to replace the CEO after losing the edge in the weight loss drugs Novo Nordisk to replace the CEO after losing the edge in the weight loss drugs admin • 16.05.2025 16:11 Paylaş: Twitter Facebook WhatsApp Reddit Pinterest The Danish drug manufacturer, which makes Ozembic and Wegovy, saw its series fall as competition in the weight loss market that has grown still. ← Springsteen, England, explodes the Trump administration as a “traditional” Democrats move to block over $ 3 billion of sales in Qatar and United Arab Emirates → Tavsiye Edilen Haberler 12/28/2025 Sam Altman seeks candidate to address AI risks 12/28/2025 Two Dead in Vehicle Attack and Stabbing Incident in Israel, Authorities Report 12/27/2025 A Chaotic Regime and Financial Chains: Venezuela’s Hidden Blockade Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ
